An interventional study of Virtual Training in Age-related Hearing Loss, sponsored by University of Massachusetts, Amherst. Status unknown at 3 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-06.
Sponsored by University of Massachusetts, Amherst · Not applicable, Interventional, and Other
The purpose of this study is to develop and test a multicomponent hearing care intervention for the PACE staff members in order to learn more about communication and engagement.
The long-term objective of this proposal is to increase the accessibility and affordability of hearing loss treatment for older adults with hearing loss, with a particular interest in adults that have mild cognitive impairment (MCI) or dementia. Age-related hearing loss (ARHL) in persons with MCI or dementia may exacerbate dementia-related symptoms such as depression, apathy, agitation/aggression. Moreover, engagement and activity participation are recognized as critical aspects of dementia care management, but those individuals who also experience ARHL are at a disadvantage. A pilot testing of behavioral communication intervention will be completed at multiple Program for All-inclusive Care for the Elderly (PACE) sites in New England. A multicomponent hearing care intervention will be tested that includes staff training and non-custom personal amplification use with older adults in a group care setting. This feasibility study will lead to the refinement of the intervention protocols to be used in a future grant application that will test the real-world efficacy of the intervention.
66 studies on the registry are indexed under Presbycusis; 21 are open to participants now.
This study's planned enrollment of 50 is below the median of 60 across 45 interventional studies indexed under Presbycusis.
Browse Presbycusis studies →University of Massachusetts, Amherst is the lead sponsor of 48 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will complete a baseline questionnaire followed by immediate virtual training, and complete a post-training questionnaire. Participants will also be asked to complete a questionnaire 1-month, 3-months, and 6-months post-training.
Behavioral: Virtual Training
Participants will receive a virtual training that is tailored to age-related hearing loss, use of non-custom personal amplification devices, and communication strategies.
Change From Baseline on a Hearing communication Knowledge Assessment at 1 Month.
Participants will complete a questionnaire to monitor retention of communication strategies and behaviors.
Time frame: 1 month follow-up
Change From Baseline on a Hearing communication Knowledge Assessment at 3 Months.
Participants will complete a questionnaire to monitor retention of communication strategies and behaviors.
Time frame: 3 month follow-up
Change From Baseline on a Hearing communication Knowledge Assessment at 6 Months.
Participants will complete a questionnaire to monitor retention of communication strategies and behaviors.
Time frame: 6 month follow-up
Qualitative Interviews
We will purposefully sample staff members whose quantitative results indicate that they were either successful or unsuccessful in learning and using new communication behaviors.
Time frame: 6-12 months post training
Plan to share: No
Ran from Dec 2020 to primary completion in Nov 2021, 11 months.
Of 25 interventional studies with no phase under Presbycusis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 58. This study's 11 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Massachusetts, Amherst